High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas

Clinical Cancer Research

Volumn 5, Issue 6, 1999, Pages 1491-1496

  Tang, Xao X ^a   Evans, Audrey E ^a   Zhao, Huaqing ^a   Cnaan, Avital ^a   London, Wendy ^b   Cohn, Susan L ^c   Brodeur, Garrett M ^a   Ikegaki, Naohiko ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; PROTEIN TYROSINE KINASE;

ARTICLE; CANCER GROWTH; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EPHRIN-B2; EPHRIN-B3; GENES, MYC; HUMANS; NEOPLASM STAGING; NEUROBLASTOMA; PROGNOSIS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, TRKA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

EID: 0032979215     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Brodeur, G. M. Molecular basis for heterogeneity in human neuroblastomas. Eur. J. Cancer, 31A: 505-510, 1995.
2. Brodeur, G. M., Seeger, R. C., Barrett, A., Berthold, F., Castleberry, R. P., et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J. Clin. Oncol., 11: 1466-1477, 1993.
3. Brodeur, G. M., Maris, J. M., Yamashiro, D. J., Hogarty, M. D., and White, P. S. Biology and genetics of human neuroblastomas. J. Pediatr. Hematol. Oncol., 19: 93-101, 1997.
4. Silber, J. H., Evans, A. E., and Fridman, M. Models to predict outcome from childhood neuroblastoma: the role of serum ferritin and tumor histology. Cancer Res., 51: 1426-1433, 1991.
5. Nakagawara, A., Azar, C. G., Scavarda, N. J., and Brodeur, G. M. Expression and function of TRK-B and BDNF in human neuroblastomas. Mol. Cell. Biol., 14: 759-767, 1994.
6. Tessier-Lavigne, M. Eph receptor tyrosine kinases, axon repulsion, and the development of topographic maps. Cell, 82: 345-348, 1995.
7. Winslow, J. W., Moran, P., Valverde, J., Shih, A., Yuan, J. Q., Wong, S. C., Tsai, S. P., Goddard, A., Henzel, W. J., Hefti, F., Beck, K. D., and Caras, I. W. Cloning of AL-1, a ligand for an Eph-related tyrosine kinase receptor involved in axon bundle formation. Neuron. 14: 973-981, 1995.
8. Wang, H. U., and Anderson, D. J. Eph family transmembrane ligands can mediate repulsive guidance of trunk neural crest migration and motor axon outgrowth. Neuron. 18: 383-396, 1997.
9. Lumsden, A., and Krumlauf, R. Patterning the vertebrate neuraxis. Science (Washington DC), 274: 1109-1115, 1996.
10. Magal, E., Holash, J. A., Toso, R. J., Chang, D., Lindberg, R. A., and Pasquale, E. B. B61, a ligand for the Eck receptor protein-tyrosine kinase, exhibits neurotrophic activity in cultures of rat spinal cord neurons. J. Neurosci. Res., 43: 735-744, 1996.
11. Daniel, T. O., Stein, E., Cerretti, D. P., St. John, P. L., Robert, B., and Abrahamson, D. R. ELK and LERK-2 in developing kidney and microvascular endothelial assembly. Kidney Int., 57 (Suppl.): S73-S81, 1996.
12. Maru, Y., Hirai, H., and Takaku, F. Overexpression confers an oncogenic potential upon the eph gene. Oncogene. 5: 445-447, 1990.
13. Kiyokawa, E., Takai, S., Tanaka, M., Iwase, T., Suzuki, M., Xiang, Y. Y., Naito, Y., Yamada, K., Sugimura, H., and Kino, I. Overexpression of ERK, an EPH family receptor protein tyrosine kinase, in various human tumors. Cancer Res., 54: 3645-3650, 1994.
14. Stein, E., Lane, A. A., Cerretti, D. P., Schoecklmann, H. O., Schroff, A. D., Van Etten, R. L., and Daniel, T. O. Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses. Genes Dev., 12: 667-678, 1998.
15. Eph Nomenclature Committee. Unified nomenclature for Eph family receptors and their ligands, the ephrins. Cell, 90: 403-404, 1997.
16. Gale, N. W., Holland, S. J., Valenzuela, D. M., Flenniken, A., Pan, L., Ryan, T. E., Henkemeyer, M., Strebhardt, K., Hirai, H., Wilkinson, D. G., Pawson, T., Davis, S., and Yancopoulos, G. D. Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis. Neuron, 17: 9-19, 1996.
17. Ikegaki, N., Tang, X. X., Liu, X. G., Biegel, J. A., Allen, C. Yoshioka, A., Sulman, E. P., Brodeur, G. M., and Pleasure, D. E. Molecular characterization and chromosomal localization of DRT (EPHT3): a developmentally regulated human protein-tyrosine kinase gene of the EPH family. Hum. Mol. Genet., 4: 2033-2045, 1995.
18. Auffray, C., and Rougeon, F. Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur. J. Biochem., 107: 303-314, 1980.
19. Svensson, T., Ryden, M., Schilling, F. H., Dominici, C., Sehgal, R., Ibanez, C. F., and Kogner, P. Coexpression of mRNA for the full-length neurotrophin receptor trk-C and trk-A in favourable neuroblastoma. Eur. J. Cancer, 33: 2058-2063, 1997.
20. Yamashiro, D. J., Nakagawara, A., Ikegaki, N., Liu, X. G., and Brodeur, G. M. Expression of TrkC in favorable human neuroblastomas. Oncogene, 12: 37-41, 1996.
21. Tang, X. X., Brodeur, G. M., Campling, B. G., and Ikegaki, N. Co-expression of transcripts encoding EPHB receptor protein-tyrosine kinases and their ephrin-B ligands in human small cell lung carcinoma. Clin. Cancer Res., 5: 455-460, 1999.
22. Tang, X. X., Biegel, J. A., Nycum, L. M., Yoshioka, A., Brodeur, G. M., Pleasure, D. E., and Ikegaki, N. cDNA cloning, molecular characterization, and chromosomal localization of NET(EPHT2). a human EPH-related receptor protein-tyrosine kinase gene preferentially expressed in brain. Genomics, 29: 426-437, 1995.
23. Tang, X. X., Pleasure, D. E., and Ikegaki, N. cDNA cloning, chromosomal localization, and expression pattern of EPLG8, a new member of the EPLG gene family encoding ligands of EPH-related protein-tyrosine kinase receptors. Genomics, 41: 17-24, 1997.
24. Nakagawara, A., Arima-Nakagawara, M., Scavarda, N. J., Azar, C. G., Cantor, A. B., and Brodeur, G. M. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N. Engl. J. Med., 328: 847-854, 1993.
25. Suzuki, T., Bogenmann, E., Shimada, H., Stram, D., and Seeger, R. C. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. J. Natl. Cancer Inst., 85: 377-384, 1993.
26. Kogner, P., Barbany, G., Dominici, C., Castello, M. A., Raschella, G., and Persson, H. Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. Cancer Res., 53: 2044-2050, 1993.
27. Gross, N., Beretta, C., Peruisseau, G., Jackson, D., Simmons, D., and Beck, D. CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation. Cancer Res., 54: 4238-4242, 1994.
28. Combaret, V., Gross, N., Lasset, C., Frappaz, D., Peruisseau, G., Philip, T., Beck, D., and Favrot, M. C. Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatnc neuroblastomas. J. Clin. Oncol., 14: 25-34, 1996.
29. Schmidt, M. L., Salwen, H. R., Manohar, C. F., Ikegaki, N., and Cohn, S. L. The biological effects of antisense N-myc expression in human neuroblastoma. Cell Growth Differ., 5: 171-178, 1994.
30. Gurniak, C. B., and Berg, L. J. A new member of the Eph family of receptors that lacks protein tyrosine kinase activity. Oncogene, 13: 777-786, 1996.
31. Matsuoka, H., Iwata, N., Ito, M., Shimoyama, M., Nagata, A., Chihara, K., Takai, S., and Matsui, T. Expression of a kinase-defective Eph-like receptor in the normal human brain. Biochem. Biophys. Res. Commun., 235: 487-492, 1997.
32. Bruckner, K., Pasquale, E. B., and Klein, R. Tyrosine phosphorylation of transmembrane ligands for Eph receptors. Science (Washington DC), 275: 1640-1643, 1997.